Skip to main content

3 Result(s)

within Akriti G Jain Remove this filter

and

  1. Article

    Open Access

    Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML

    Dasatinib is one of the second generation tyrosine kinase inhibitors (TKI) which is approved for the treatment of patients with chronic phase CML (CP-CML) both in the front line and in the second line setting....

    Akriti G Jain, Quinto Gesiotto, Somedeb Ball, Lisa Nodzon… in Annals of Hematology (2024)

    Download PDF (662 KB) View Article

  2. No Access

    Article

    Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes

    The Molecular International Prognostic Scoring System (IPSS-M) is a novel risk stratification model for myelodysplastic syndromes (MDS) that builds on the IPSS and IPSS-R by incorporating mutational data. The ...

    Luis E. Aguirre, Najla Al Ali, David A. Sallman, Somedeb Ball, Akriti G. Jain… in Leukemia (2023)

  3. No Access

    Article

    Can we lower the platelet threshold of ≥ 50 × 109/L for performing a lumbar puncture safely in patients with hematological malignancies?

    Lumbar punctures (LP) are routinely used to administer intrathecal chemotherapy for children and adults with hematologic malignancies. The current guidelines suggest a platelet threshold of ≥ 50 × 109/L prior to ...

    Aryanna Jordan, Akriti G. Jain, Gautam Krishna Koipallil… in Annals of Hematology (2023)